ФЦ МБЛС счел целесообразным информировать медицинскую общественность, а также потребителей,

Notify clients that anaphylaxis has actually been reported with substances contained in OXYCONTIN. Suggest people how to acknowledge this kind of response and when to seek health-related notice [see CONTRAINDICATIONS , ADVERSE REACTIONS].При применении с гипотензивны�